Clinical Gains from Including Both Dextroamphetamine and Methylphenidate in Stimulant Trials
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. METHOD: Thirty-six medication-naïve children ages 9-14 years diagnosed with attention-deficit/hyperactivity disorder (ADHD) were enrolled for 6 weeks in a crossover trial, with 2 weeks of methylphenidate, dextroamphetamine, and placebo, in a randomly assigned, counterbalanced sequence. Outcome measures constituted a computer-based continuous performance test combined with a motion tracking system (Qb Test) and an ADHD questionnaire rated by parents and teachers. RESULTS: Group analyses found significant treatment effects of similar size for the two stimulants on both outcome measures. Single-subject analyses revealed that each stimulant produced a favourable response in 26 children; however, an individual child frequently responded qualitatively or quantitatively differently to the two stimulants. By including both stimulants in the trial, the number of favorable responders increased from 26 (72%) to 33 (92%). In children with favorable responses of unequal strength to the two stimulants, a shift from inferior drug to best drug was associated with a 64% mean increase in the overall response strength score, as measured by the ADHD questionnaire. CONCLUSIONS: The likelihood of a favorable response and optimal response strength is increased by including both stimulants in the stimulant trial. The study was first registered in clinical trials 28 September 2010. Clinical Trials.gov Identifier: NCT01220440.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
JENSEN, P. S., HINSHAW, S. P., SWANSON, J. M., GREENHILL, L. L., CONNERS, C. K., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G., HECHTMAN, L., HOZA, B., et al. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00008 · Cited by 591 · cited 2×
“Its core behavioral symptoms of inattention, impulsivity, and hyperactivity are associated with impaired academic performance and social functioning and a higher risk of comorbid externalized and internalized psychiatric disorders ( Jensen et al. 2001a).”
BackgroundComparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485 · cited 2×
“…in children and adolescents found the effect size of amphetamine products to be moderately but significantly greater than that of methylphenidate, although the authors noted that comparisons among stimulants are hindered by the absence of direct comparative trials (Faraone and Buitelaar 2010).”
BackgroundResultHalmøy, A., Fasmer, O. B., Gillberg, C., & Haavik, J. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708329777 · Cited by 317 · cited 1×
“2008), improved occupational outcome (Halmoy et al. 2009), and reduced risk of subsequent psychiatric comorbid disorder (Biederman et al.”
BackgroundStimulant treatment over five years: adherence, effectiveness, and adverse effects
Charach, A., Ickowicz, A., & Schachar, R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200405000-00009 · Cited by 315
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers
GREENHILL, L. L., ABIKOFF, H. B., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., ELLIOTT, G., HECHTMAN, L., HINSHAW, S. P., HOZA, B., JENSEN, P. S., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199610000-00017 · Cited by 297
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
GREENHILL, L. L., SWANSON, J. M., VITIELLO, B., DAVIES, M., CLEVENGER, W., WU, M., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00012 · Cited by 287
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009) · Pediatrics · doi:10.1542/peds.2008-3347 · Cited by 246 · cited 2×
“Although long-term effects are less well studied, reduced ADHD symptoms (Charach et al. 2004), improved academic outcome (Powers et al. 2008), improved occupational outcome (Halmoy et al. 2009), and reduced risk of subsequent psychiatric comorbid disorder (Biederman et al. 2009) are reported.”
BackgroundEvans, S. W., Pelham, W. E., Smith, B. H., Bukstein, O., Gnagy, E. M., Greiner, A. R., Altenderfer, L., & Baron-Myak, C. (2001) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.9.2.163 · Cited by 185 · cited 2×
“To measure a drug response, a standard effect size value (ES) was calculated for parent and teacher separately by subtracting the mean weekly full scale score in the treatment condition from the mean weekly full scale score in the placebo condition and dividing the result by the SD of the placebo (Evans et al. 2001).”
MethodSkirbekk, B., Hansen, B. H., Oerbeck, B., & Kristensen, H. (2011) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-011-9488-4 · Cited by 141 · cited 1×
“Sluggish cognitive tempo (SCT) is found to be highly correlated with ADHD inattention symptoms (Skirbekk et al. 2011), and three SCT items selected for the ADHD questionnaire correspond to items included in the Achenbach System of Empirically Based Assessment.”
MethodGomez, R., Burns, G. L., Walsh, J. A., & De Moura, M. A. (2003) · Psychological Assessment · doi:10.1037/1040-3590.15.1.3 · Cited by 115
Arnold, L. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280073008 · Cited by 104 · cited 2×
“These results are in the same range as those reported in several other studies (Arnold et al. 1978; Elia et al. 1991; Arnold 2000).”
ResultPowers, R. L., Marks, D. J., Miller, C. J., Newcorn, J. H., & Halperin, J. M. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.021 · Cited by 104
Efron, D., Jarman, F., & Barker, M. (1997) · PEDIATRICS · doi:10.1542/peds.100.6.e6 · Cited by 94
Rapport, M. D., Jones, J. T., DuPaul, G. J., Kelly, K. L., Gardner, M. J., Tucker, S. B., & Shea, M. S. (1987) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp1604_6 · Cited by 91 · cited 2×
“Cb-CPTs consistently demonstrate responsiveness to the effect of stimulants (Rapport et al. 1987; Pelham et al. 1990; Tabori-Kraft et al. 2007; Teicher et al. 2008; Fernandez-Jaen et al. 2009), and an absence of practice effects is reported (Fernandez-Jaen et al.”
BackgroundLis, S., Baer, N., Stein‐en‐Nosse, C., Gallhofer, B., Sammer, G., & Kirsch, P. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01549.x · Cited by 84
Brocki, K. C., Tillman, C. M., & Bohlin, G. (2010) · European Journal of Developmental Psychology · doi:10.1080/17405620801937764 · Cited by 53 · cited 1×
“Test performances were recorded and scored by a computer program using age-adjusted norms developed by Qb Tech with proven reliability and validity (Bergfalk 2003; Brocki et al. 2010), and test results were expressed in q-scores (mean = 0, SD = 1).”
Method
Cited by
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122
Tamminga, H. G. H., Reneman, L., Huizenga, H. M., & Geurts, H. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000350 · Cited by 82
“…SST SSRT 0.60 (0.28) Fixede Single challenge IR, 0.6 mg/kg Pliszka et al. (2007)dd 12 (67) 12.3 (1.7)/9–15 42 – SST SSRT 0.19 (0.28) Optimal Single challenge IR, mean = 13.7 mg Ramtvedt et al. (2013)ee 36 (81) 11.4 (1.4)/9–14 55 100 CPTff Inattention compositegg 0.28 (0.19) Fixed 3 d.d. 2 weeks/…”
InfluentialHolmskov, M., Storebø, O. J., Moreira-Maia, C. R., Ramstad, E., Magnusson, F. L., Krogh, H. B., Groth, C., Gillies, D., Zwi, M., Skoog, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178187 · Cited by 58
“Only two parallel group trials [38,39] and two cross-over trials [40,41] used co-interventions.”
Background
Metadata
- Authors
- Ramtvedt, B. E., Røinås, E., Aabech, H. S., & Sundet, K. S.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-11
- Volume
- 23
- Issue
- 9
- Pages
- 597-604
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2070178323
- Cited by
- 30
- References
- 19
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.